OUR PIPELINE

Preclinical
Phase 1
Phase 2
Phase 3 / Confirmatory
Our Partner
Hematology
Loncastuximab Tesirine (ADCT-402, Lonca)
Approved
DLBCL
Confirmatory
DLBCL, combo with rituximab
Pivotal
Follicular lymphoma
ADCT-602
Phase 1a
Acute lymphoblastic leukemia
Hematology
ALLO-715
Phase 1
Multiple myeloma
Phase 1
Multiple myeloma, combo with nirogacestat
ALLO-605 (TurboCARTM/MM)
Phase 1
Multiple myeloma
ALLO-316 (CD70/AML)
Preclinical
Acute myeloid leukemia
ALLO-819 (FLT3/AML)
Preclinical
Acute myeloid leukemia
Solid Tumor
ADCT-601
Phase 1a
Various solid tumors
ADCT-901
Phase 1a
Various solid tumors
Solid Tumor
ALLO-316 (CD70/RCC)
Phase 1
Renal cell carcinoma
DLL3 (SCLC)
Preclinical
Small cell lung cancer
Lymphodepletion
ALLO-647 (Anti-CD52 mAb)
Phase 1
Lymphodepletion